Abstract
Introduction
Intra-arterial (IA) thrombolysis with plasminogen activator is well-known, but the use of IA tirofiban as an adjuvant for IA thrombolysis is not well-known. We investigated the feasibility of IA tirofiban as an adjuvant after unsuccessful IA recanalization with urokinase (UK) for acute ischemic stroke.
Methods
We retrospectively analyzed all 16 consecutive patients (11 men and five women; mean age, 61.3 years; range, 36–85 years) who were treated with IA tirofiban after isolated IA thrombolysis with UK or bridging therapy with systemic recombinant tissue plasminogen activator (rt-PA; 0.6 mg/Kg) and IA UK for acute ischemic stroke. Outcome measures included angiographic recanalization (thrombolysis in cerebral infarction, TICI), symptomatic and asymptomatic intracerebral hemorrhage (ICH), mortality, and functional independence at 3 months (modified Rankin Scale, 0–2).
Results
Among the 16 patients treated with IA tirofiban as an adjuvant, 10 patients had conventional dose (<25 ug/kg, bolus) and six patients had high dose (≥25 ug/kg, bolus) of IA tirofiban after unsuccessful IA thrombolysis whether systemic rt-PA used or not. Successful angiographic recanalization (TICI grade 2b or 3) was achieved in 13 patients (13/16) and a functional independence at 3 months in eight patients (8/16). Three months after therapy, three patients had died. There were two patients of symptomatic ICH and four asymptomatic ICH.
Conclusion
Conventional dose of IA tirofiban as an adjuvant during IA thrombolysis for acute ischemic stroke seems feasible. However, further dose escalation studies should be performed regarding the IA use of tirofiban for acute ischemic stroke.
Similar content being viewed by others
References
Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282(21):2003–2011
Mandava P, Kent TA (2007) Intra-arterial therapies for acute ischemic stroke. Neurology 68(24):2132–2139
Kang D-H, Hwang Y-H, Kim Y-S (2011) Direct thrombus retrieval using the reperfusion catheter of the penumbra system: forced-suction thrombectomy in acute ischemic stroke. AJNR 32:283–287
Kim SM, Lee DH, Kwon SU, Choi CG, Kim SJ, Suh DC (2011) Treatment of acute ischemic stroke: feasibility of primary or secondary use of a self-expanding stent (Neuroform) during local intra-arterial thrombolysis. Neuroradiology. doi:10.1007/s00234-010-0813-3
Roth C, Papanagiotou P, Behnke S, Walter S, Haass A, Becker C, Fassbender K, Politi M, Korner H, Romann MS, Reith W (2010) Stent-assisted mechanical recanalization for treatment of acute intracerebral artery occlusions. Stroke 41(11):2559–2567
Qureshi AI, Siddiqui AM, Kim SH, Hanel RA, Xavier AR, Kirmani JF, Suri MF, Boulos AS, Hopkins LN (2004) Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 25(2):322–328
Janjua N, Alkawi A, Suri MF, Qureshi AI (2008) Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke. AJNR Am J Neuroradiol 29(2):253–258
Qureshi AI, Hussein HM, Abdelmoula M, Georgiadis AL, Janjua N (2009) Subacute recanalization and reocclusion in patients with acute ischemic stroke following endovascular treatment. Neurocrit Care 10(2):195–203
Hussain MS, Lin R, Moskowitz S, Bain M, Gonugunta V, Rasmussen PA, Masaryk TJ, Horowitz MB, Jovin T, Gupta R (2010) Symptomatic delayed reocclusion after initial successful revascularization in acute ischemic stroke. J Stroke Cerebrovasc Dis 19(1):36–39
Qureshi AI, Luft AR, Sharma M, Guterman LR, Hopkins LN (2000) Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: part I—pathophysiological and pharmacological features. Neurosurgery 46(6):1344–1359
Deshmukh VR, Fiorella DJ, Albuquerque FC, Frey J, Flaster M, Wallace RC, Spetzler RF, McDougall CG (2005) Intra-arterial thrombolysis for acute ischemic stroke: preliminary experience with platelet glycoprotein IIb/IIIa inhibitors as adjunctive therapy. Neurosurgery 56(1):46–54, discussion 54–55
Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D (2005) Intravenous glycoprotein IIb/IIIa inhibitor (tirofiban) followed by intra-arterial urokinase and mechanical thrombolysis in stroke. AJNR Am J Neuroradiol 26(10):2595–2601
Mangiafico S, Cellerini M, Nencini P, Gensini G, Inzitari D (2005) Intravenous tirofiban with intra-arterial urokinase and mechanical thrombolysis in stroke: preliminary experience in 11 cases. Stroke 36(10):2154–2158
Qureshi AI, Suri MF, Ali Z, Ringer AJ, Boulos AS, Nakada MT, Alberico RA, Martin LB, Guterman LR, Hopkins LN (2005) Intraarterial reteplase and intravenous abciximab for treatment of acute ischemic stroke. A preliminary feasibility and safety study in a non-human primate model. Neuroradiology 47(11):845–854
Memon MZ, Natarajan SK, Sharma J, Mathews MS, Synder KV, Siddiqui AH, Hopkins LN, Levy EI (2011) Safety and feasibility of intraarterial eptifibatide as a revascularization tool in acute ischemic stroke. J Neurosurg 114(4):1008–1013
Eckert B, Koch C, Thomalla G, Kucinski T, Grzyska U, Roether J, Alfke K, Jansen O, Zeumer H (2005) Aggressive therapy with intravenous abciximab and intra-arterial rtPA and additional PTA/stenting improves clinical outcome in acute vertebrobasilar occlusion: combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (FAST): results of a multicenter study. Stroke 36(6):1160–1165
Pfefferkorn T, Mayer TE, Opherk C, Peters N, Straube A, Pfister HW, Holtmannspotter M, Muller-Schunk S, Wiesmann M, Dichgans M (2008) Staged escalation therapy in acute basilar artery occlusion: intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: preliminary experience in 16 patients. Stroke 39(5):1496–1500
Kwon OK, Lee KJ, Han MH, Oh CW, Han DH, Koh YC (2002) Intraarterially administered abciximab as an adjuvant thrombolytic therapy: report of three cases. AJNR Am J Neuroradiol 23(3):447–451
Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38(5):1655–1711
Qureshi AI, Pande RU, Kim SH, Hanel RA, Kirmani JF, Yahia AM (2002) Third generation thrombolytics for the treatment of ischemic stroke. Curr Opin Investig Drugs 3(12):1729–1732
White HD (1997) Unmet therapeutic needs in the management of acute ischemia. Am J Cardiol 80(4A):2B–10B
Kawano K, Aoki I, Aoki N, Homori M, Maki A, Hioki Y, Hasumura Y, Terano A, Arai T, Mizuno H, Ishikawa K (1998) Human platelet activation by thrombolytic agents: effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression. Am Heart J 135(2 Pt 1):268–271
Qureshi AI, Harris-Lane P, Kirmani JF, Janjua N, Divani AA, Mohammad YM, Suarez JI, Montgomery MO (2006) Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. Neurosurgery 59(4):789–796, discussion 796–797
Nordt TK, Moser M, Kohler B, Ruef J, Peter K, Kubler W, Bode C (1998) Augmented platelet aggregation as predictor of reocclusion after thrombolysis in acute myocardial infarction. Thromb Haemost 80(6):881–886
Mandava P, Thiagarajan P, Kent TA (2008) Glycoprotein IIb/IIIa antagonists in acute ischaemic stroke: current status and future directions. Drugs 68(8):1019–1028
Manoharan G, Adgey AA (2004) Considerations in combination therapy: fibrinolytics plus glycoprotein IIb/IIIa receptor inhibitors in acute myocardial infarction. Clin Cardiol 27(7):381–386
Szabo S, Walter T, Etzel D, Ehlers R, Kazmaier S, Beyer ME, Hoffmeister HM (2003) Benefical effects of reteplase in combination with abciximab: platelet/leukocyte interactions and coagulation system. Int J Clin Pharmacol Res 23(2–3):37–40
Adams HP Jr, Effron MB, Torner J, Davalos A, Frayne J, Teal P, Leclerc J, Oemar B, Padgett L, Barnathan ES, Hacke W (2008) Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 39(1):87–99
Junghans U, Seitz RJ, Aulich A, Freund HJ, Siebler M (2001) Bleeding risk of tirofiban, a nonpeptide GPIIb/IIIa platelet receptor antagonist in progressive stroke: an open pilot study. Cerebrovasc Dis 12(4):308–312
Philipps J, Thomalla G, Glahn J, Schwarze M, Rother J (2009) Treatment of progressive stroke with tirofiban—experience in 35 patients. Cerebrovasc Dis 28(5):435–438
Pancioli AM, Broderick J, Brott T, Tomsick T, Khoury J, Bean J, del Zoppo G, Kleindorfer D, Woo D, Khatri P, Castaldo J, Frey J, Gebel J Jr, Kasner S, Kidwell C, Kwiatkowski T, Libman R, Mackenzie R, Scott P, Starkman S, Thurman RJ (2008) The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trial. Stroke 39(12):3268–3276
Qureshi AI, Hussein HM, Janjua N, Harris-Lane P, Ezzeddine MA (2008) Postprocedure intravenous eptifibatide following intra-arterial reteplase in patients with acute ischemic stroke. J Neuroimaging 18(1):50–55
Langer D, Alexander M, Janardhan V, Hartmann M, Jansen O, Sit SP, Yavagal D, Stingele R, DeMuth G, Bose A, Clark W, Lutsep H, Barnwell S, Nesbit G, Egan R, North E, Yanase L, Lowenkopf T, Petersen B, Grunwald IQ, Mayer T, Doerfler A, Struffert T, Engelhorn T, Richter G, Grunwald IQ, Reith W, Berkefeld J, Madison M, Myers M, Goddard J, Lassig J, Lopes D, Shownkeen H, Echiverri H, Nour F, Mazumdar A, Budzik R, Pema P, Frei D, Huddle D, Bellon R, Heck D, Ferguson R, McDougall C, Flaster M, Frey J, Albuquerque F, Malkoff M, Zaidat O, Branca V, Ahktar N, Rymer M, Rai A, Brooks C, Carpenter J, Popovich T, Chaloupka J, Hellinger F, Rasmussen P, Masaryk T, Fiorella D, Woo H, Rudolph S, Spiegel G, Silverman I, Ohki S, Gomes J, Trial PPS (2009) The Penumbra Pivotal Stroke Trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8):2761–2768
Danzi GB, Capuano C, Sesana M, Baglini R (2004) Safety of a high bolus dose of tirofiban in patients undergoing coronary stent placement. Catheter Cardiovasc Interv 61(2):179–184
Marmur JD, Poludasu S, Agarwal A, Manjappa N, Cavusoglu E (2008) High-dose tirofiban administered as bolus-only during percutaneous coronary intervention. J Invasive Cardiol 20(2):53–58
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Diez-Tejedor E, Trouillas P (1998) Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352(9136):1245–1251
Acknowledgments
We thank Dr. Sarawana CM, Kuala Lumpur Hospital, Malaysia and Bonnie Hami, MA, USA for their English editorial assistance.
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwon, JH., Shin, S.H., Weon, Y.C. et al. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients. Neuroradiology 53, 779–785 (2011). https://doi.org/10.1007/s00234-011-0939-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00234-011-0939-y